3 healthcare shares that I want in my portfolio

CSL Limited (ASX:CSL) shares are one of three that I think investors ought to consider buying in the healthcare sector…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

One area of the market that I'm especially bullish on over the long-term is the healthcare sector.

I believe this area of the market is well positioned to grow strongly over the next decade or two due to growing demand for healthcare services and the emergence of new technologies.

Three healthcare shares that I think could make great long-term investments are as follows:

CSL Limited (ASX: CSL)

CSL Limited is one of the world's leading biopharmaceutical companies. Over the last decade the company has consistently grown its sales and earnings at a strong rate thanks to its core business and ever-expanding portfolio of lucrative products. I don't expect this to change any time soon and believe it would be a fantastic share to buy and hold.

ResMed Inc. (ASX: RMD)

Another top option in the healthcare sector in my opinion is ResMed. It is a medical device company with a focus on the sleep treatment market. Like CSL, it has a long track record of generating solid earnings growth and creating wealth for its shareholders. Pleasingly, due to its leading products, wide distribution, and growing market, I believe the company is well-positioned to continue this trend for a long time to come.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara Health Technologies has been growing at an explosive rate over the last 18 months thanks to its popular breast imaging analytics and analysis software. In its recent half year results management advised that 5.4% of women being screened (2.1 million) in the United States are now being actively analysed by a Volpara product. This is expected to grow to 9% by the end of the financial year. Importantly, with much of its breast imaging analytics data flowing to the cloud, the company now has one of the biggest cross-vendor data sets in mammography. Management believes this is a powerful asset not only for finding key insights to help detect breast cancer early but also for developing new products that can help increase its average price per patient.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A group of people of all ages, size and colour line up against a brick wall using their devices.
Growth Shares

3 high-quality ASX 200 shares for beginners to buy and hold

For beginners, I would focus on quality businesses that can keep growing and become more valuable over time.

Read more »

long term and short term on white cubes
Growth Shares

2 top ASX shares to buy and hold for the next decade

These investments could generate significant returns.

Read more »

A woman pulls devil rock'n'roll hands and sticks her tongue out whilst headbanging, she's rocking it.
Growth Shares

This ASX tech stock has exploded 75% in a month, but can it climb higher?

The most optimistic broker sees another 90% upside ahead!

Read more »

A couple sit in their home looking at a phone screen as if discussing a financial matter.
Share Market News

2 beaten-down ASX shares to hold until 2036

These stocks look well-positioned for growth over the next decade.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

3 amazing ASX growth shares to buy and hold forever

Looking to make long-term investments? Here are three to consider.

Read more »

Robot humanoid using artificial intelligence on a laptop.
Growth Shares

Why Megaport just landed its biggest ever AI infrastructure contract

Megaport has had a great week. It seems large clients are starting to appreciate its vertically integrated product offering.

Read more »

A graphic image of the world globe surrounded by tech images is superimposed on the setting of an office where three businesspeople are speaking together while standing.
Growth Shares

Is the TechnologyOne share price an opportunity too good to pass up?

Should investors look at this tech stock as a great opportunity?

Read more »

A man leaps as high as he can over his friends into a pool.
Share Market News

Down 42% this year, is it time to jump into Life360 shares?

Crashing shares: golden opportunity or value trap?

Read more »